Literature DB >> 2573556

Association of IDDM and attenuated response of 2',5'-oligoadenylate synthetase to yellow fever vaccine.

V Bonnevie-Nielsen1, M L Larsen, J J Frifelt, B Michelsen, A Lernmark.   

Abstract

Basal and yellow fever vaccination-induced 2',5'-oligoadenylate synthetase (2',5'A) activity was determined in blood mononuclear cells (peripheral blood lymphocytes [PBLs]) from insulin-dependent diabetes mellitus (IDDM) and matched control subjects. The live attenuated yellow fever vaccine represented a primary stimulus in all subjects. First, basal 2',5'A activity increased severalfold in response to yellow fever vaccination. In IDDM subjects, this increase was significantly lower (P = .025). Second, the 2',5'A activity increased proportionately to the higher basal 2',5'A activity in IDDM subjects. In control subjects, the increase in 2',5'A activity was not dependent on the basal activity. There was no relationship between basal or stimulated 2',5'A activity and age, sex, duration of IDDM, age at onset of IDDM, metabolic control, or HLA-DQ beta-chain gene polymorphism. There is a direct relationship between 2',5'A activity and latent viral infections associated with the presence of double-stranded RNA and with cellular interferons (IFNs) formed in response to viral infections. The higher basal 2',5'A activity (P = .05) in relation to the stimulated activity may therefore signify a latent infection or the presence of double-stranded RNA in PBLs of IDDM subjects. In vitro stimulation of PBLs showed increased IFN sensitivity in IDDM subjects. Analysis of 2',5'A activity is proposed to be a sensitive measure of the activation of the IFN system and the level of latent infectivity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573556     DOI: 10.2337/diab.38.12.1636

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Forward genetic dissection of innate response to infection in inbred mouse strains: selected success stories.

Authors:  S Gruenheid; P Gros
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

3.  Increased IFN-alpha-induced sensitivity but reduced reactivity of 2',5'-oligoadenylate synthetase (2,5AS) in trisomy 21 blood lymphocytes.

Authors:  A M Gerdes; M Hørder; V Bonnevie-Nielsen
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

4.  Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine.

Authors:  V Bonnevie-Nielsen; I Heron; T P Monath; C H Calisher
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

5.  Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene.

Authors:  Vagn Bonnevie-Nielsen; L Leigh Field; Shao Lu; Dong-Jun Zheng; Min Li; Pia M Martensen; Thomas B Nielsen; Henning Beck-Nielsen; Yu-Lung Lau; Flemming Pociot
Journal:  Am J Hum Genet       Date:  2005-02-24       Impact factor: 11.025

6.  Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast.

Authors:  Lianghao Ding; Jackie Stilwell; Tingting Zhang; Omeed Elboudwarej; Huijian Jiang; John P Selegue; Patrick A Cooke; Joe W Gray; Fanqing Frank Chen
Journal:  Nano Lett       Date:  2005-12       Impact factor: 11.189

Review 7.  Vaccine therapies for the prevention of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 8.  Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment.

Authors:  Brittney N Newby; Clayton E Mathews
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-14       Impact factor: 5.555

9.  Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells.

Authors:  M Li; D-J Zheng; L L Field; V Bonnevie-Nielsen
Journal:  Exp Diabetes Res       Date:  2009-10-29

Review 10.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.